Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer.

Many systemic nonhormonal regimens have been evaluated across several hundreds of randomized trials in advanced breast cancer. We aimed to quantify the relative merits of these regimens in prolonging survival.